Zobrazeno 1 - 10
of 137
pro vyhledávání: '"Kesavan, Karthikeyan"'
Publikováno v:
In Materialia May 2023 28
Autor:
Elaiyappillai, Elanthamilan, Srinivasan, Rajkumar, Johnbosco, Yesuraj, Devakumar, Premkumar, Murugesan, Kumaresan, Kesavan, Karthikeyan, Johnson, Princy Merlin
Publikováno v:
In Applied Surface Science 30 August 2019 486:527-538
Publikováno v:
Therapeutic Delivery; Jan2024, Vol. 15 Issue 1, p23-39, 17p
Autor:
Gautam, Nivedita1 (AUTHOR), Kesavan, Karthikeyan1 (AUTHOR) k7_76@rediffmail.com
Publikováno v:
Current Eye Research. Dec 2021, Vol. 46 Issue 12, p1844-1852. 9p.
Autor:
Sugirdha Sampath, Murugan Vadivelu, Abbasriyaludeen Abdul Raheem, Ravanan Indirajith, Kannabiran Parthasarathy, Kesavan Karthikeyan, Chandrasekar Praveen
Publikováno v:
Industrial & Engineering Chemistry Research. 61:9552-9566
Autor:
Ramachandran Sundaramoorthy, Murugan Vadivelu, Kulandaivel Thirumoorthy, Kesavan Karthikeyan, Chandrasekar Praveen
Publikováno v:
ChemMedChem.
Autor:
Murugan Vadivelu, Abbasriyaludeen Abdul Raheem, John Paul Raj, Jebamalai Elangovan, Kesavan Karthikeyan, Chandrasekar Praveen
Publikováno v:
Organic Letters. 24:2798-2803
4-Nitro-1,2,3-triazoles are crucial precursors for high energy materials, and their practical synthesis is a long-standing problem. Herein, we communicate a mechanochemical route for the selective synthesis of 4-nitro-1,2,3-triazoles via organocataly
Autor:
Murugan Vadivelu, Abbasriyaludeen Abdul Raheem, Bhaskaran Shankar, Kesavan Karthikeyan, Chandrasekar Praveen
Publikováno v:
Chemistry – An Asian Journal. 18
Publikováno v:
ChemMedChem. 18
Chemical structures possessing both 1,2,3-triazole and bis(indolyl)methane fragments gained considerable interest in drug synthesis owing to their established biological efficacies. However, 1,2,3-triazoles linked at the bridging position of bis(indo
Publikováno v:
Nanoparticles and Nanocarriers-Based Pharmaceutical Formulations ISBN: 9789815049787
Gene therapy aims at intercellular delivery of functional genetic material to the affected area to restore its function or block a dysfunctional gene using viral vectors (Adeno-associated virus) or non-viral vectors (liposomes, SLNs). Gene therapy fo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f27bc57f5dead5b295d986f91b4c9d51
https://doi.org/10.2174/9789815049787122010016
https://doi.org/10.2174/9789815049787122010016